The Company's EBITDA and net earnings increase by almost 75% and by 52%
respectively during the period
All amounts are in U.S. dollars
QUEBEC CITY, Nov. 7 /PRNewswire-FirstCall/ - Atrium Innovations Inc. (TSX: ATB) today announced that it had revenues of US$100.9 million for the third quarter ended September 30, 2007, up 37.7% from US$73.3 million for the corresponding quarter in 2006. Earnings before interest, taxes, depreciation and amortization (EBITDA) for the third quarter of 2007 were US$19.2 million, up 74.8% from US$11.0 million for the same period in 2006. Net earnings increased 52.2% to US$9.8 million for the quarter ended September 30, 2007, compared to US$6.4 million for the same period last year. Fully diluted earnings per share for the third quarter of 2007 were up 50.0% to US$0.30 per share compared to US$0.20 per share for the same period in 2006.
For the nine-month period ended September 30, 2007, revenues were US$272.0 million up 21.7% from US$223.6 million for the corresponding period in 2006. EBITDA for the first nine months of 2007, was US$46.9 million, an increase of 37.7% compared to the US$34.0 million for the same period last year. Net earnings increased 27.4% to US$25.0 million generating a fully diluted earnings per share of US$0.76, compared to US$19.6 million and US$0.60 earnings per share for the first nine months of 2006.
"Our results for the last quarter include an increase of almost 75% in
EBITDA. This demonstrates the soundness of our development strategy. Our
organic growth as well as our targeted acquisition plan in highly
fragmented markets are the corner stone of our success. In keeping with
this strategy, we completed on July 12, 2007, the acquisition of Mucos
Emulsions GmbH ("Mucos"), our largest acquisition to date. Mucos provides
us with a high-performance European platform that will be used as a
strategic lever and will allow us to pursue our growth in
|SOURCE Atrium Innovations Inc.|
Copyright©2007 PR Newswire.
All rights reserved